What are the Clinical Implications of Tim Hunt's Research?
Tim Hunt's discoveries have paved the way for the development of several clinical applications in cancer treatment. CDK inhibitors, such as palbociclib, ribociclib, and abemaciclib, have been approved for the treatment of certain types of breast cancer. These drugs work by inhibiting CDK4 and CDK6, thereby blocking the cell cycle and preventing cancer cell proliferation. Ongoing research aims to expand the use of CDK inhibitors to other types of cancer.
